Coronary Stents Pipeline Insight and Competitive Landscape Report 2020: Insights on 20+ Companies and Pipeline Devices – ResearchAndMarkets.com
October 9, 2020DUBLIN–(BUSINESS WIRE)–The “Coronary Stents Pipeline Insight and Competitive Landscape, 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering.
The Coronary Stents – Pipeline Insight and Competitive Landscape, 2020, report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Coronary Stents pipeline landscape. Owing to the rise in the prevalence of coronary artery diseases (CAD), the coronary stents market is witnessing remarkable growth. Significant players are focusing on expanding their geographical reach, for dominating the current market.
According to the Centre for Disease Control and Prevention, about one-third of the population in the U.S. is obese. The change in lifestyle such as physical inactivity, smoking, drinking, and mistimed and unhealthy food habits are among the major reasons leading to health problems such as obesity, hypertension, arterial blockage, and others. Therefore, owning to all this, there is a significant rise in the pipeline of coronary stents recently.
This reports provides a detailed study of the emerging coronary stents devices along with competitive landscape to help better understand the market.
Report Highlights
- Extensive coverage of the Coronary Stents under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Coronary Stents and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
- The report consists of in depth analysis of pipeline products based on various parameters
Coronary Stents Report Insights
- Coronary Stents – Pipeline Analysis
- Coronary Stents – Unmet Need
- Coronary Stents – Market Dynamics
- Coronary Stents – Future Perspectives and Conclusion
- Coronary Stents – Analyst Views
Key Questions
- What are significant companies in this segment, their information, analysis, and insights to improve R&D strategies?
- How to identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage?
- What are important and diverse types of Coronary Stents under development?
- What are market-entry and market expansion strategies in Coronary Stents?
- What are some of the mergers and acquisitions and to identify major players with the most promising pipeline?
- What is in-depth analysis of the product’s current stage of development, territory and estimated launch date?
Key Players
- REVA Medical Inc
- Rontis AG
- S3V Vascular Technologies
- Sahajanand Medical Technologies Pvt Ltd
- Shanghai Bio-heart Biological Technology Co Ltd
- Stentys SA
- Svelte Medical Systems Inc
- Tepha Inc
- Terumo Corp
- TissueGen Inc
- TrendyMED Inc.
- VasoTech Inc.
- Viller Scientific LLC
- Vornia Biomaterials Ltd
- Xenogenics Corporation
- Biotronik AG
- Cardionovum GmbH
- Concept Medical Inc
- Contego Medical LLC
- Cordis Corp
- DISA Vascular (Pty) Ltd
- Elixir Medical Corp
- Envision Scientific Pvt Ltd
- Aachen Resonance GmbH
- Abbott Vascular Inc
- Adcomp Technologies Inc.
- Aeon Bioscience
- AlviMedica Medical Technologies Inc
- Amaranth Medical Inc
- Arterius Ltd
- Atrium Medical Corp
- Bactiguard Holding AB
- Bionext Biotech Products Ltd.
- Biosten, LLC
- Systems, Inc.
- ID Nest Medical SAS
- InspireMD Inc
- Japan Stent Technology Co., Ltd.
- JW Medical Systems Ltd
- Kaneka Corp
- Kyoto Medical Planning Co Ltd
- Liaoning Biomedical Materials R&D Center Co Ltd
- Lifetech Scientific (Shenzhen) Co Ltd
- MangoGen Pharma Inc
- Manli Cardiology Ltd
- Medinol Ltd
- Medtronic plc
- Miami Cardiovascular Innovations
- Micell Technologies Inc
- MicroPort Scientific Corp
- Minvasys SAS
- MIV Therapeutics Inc
- NanoCoeur, Inc.
- Nanova, Inc
- Nesstent Ltd.
- Nexeon MedSystems Inc
- NuVascular Technologies Inc
- OrbusNeich
- Pediastent LLC
- QualiMed Innovative Medizinprodukte GmbH
- Qvanteq AG
- Relisys Medical Devices Ltd
For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/1aoejj
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Coronary Stents Pipeline Insight and Competitive Landscape Report 2020: Insights on 20+ Companies and Pipeline Devices – ResearchAndMarkets.com
October 9, 2020DUBLIN–(BUSINESS WIRE)–The “Coronary Stents Pipeline Insight and Competitive Landscape, 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering.
The Coronary Stents – Pipeline Insight and Competitive Landscape, 2020, report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Coronary Stents pipeline landscape. Owing to the rise in the prevalence of coronary artery diseases (CAD), the coronary stents market is witnessing remarkable growth. Significant players are focusing on expanding their geographical reach, for dominating the current market.
According to the Centre for Disease Control and Prevention, about one-third of the population in the U.S. is obese. The change in lifestyle such as physical inactivity, smoking, drinking, and mistimed and unhealthy food habits are among the major reasons leading to health problems such as obesity, hypertension, arterial blockage, and others. Therefore, owning to all this, there is a significant rise in the pipeline of coronary stents recently.
This reports provides a detailed study of the emerging coronary stents devices along with competitive landscape to help better understand the market.
Report Highlights
- Extensive coverage of the Coronary Stents under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Coronary Stents and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
- The report consists of in depth analysis of pipeline products based on various parameters
Coronary Stents Report Insights
- Coronary Stents – Pipeline Analysis
- Coronary Stents – Unmet Need
- Coronary Stents – Market Dynamics
- Coronary Stents – Future Perspectives and Conclusion
- Coronary Stents – Analyst Views
Key Questions
- What are significant companies in this segment, their information, analysis, and insights to improve R&D strategies?
- How to identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage?
- What are important and diverse types of Coronary Stents under development?
- What are market-entry and market expansion strategies in Coronary Stents?
- What are some of the mergers and acquisitions and to identify major players with the most promising pipeline?
- What is in-depth analysis of the product’s current stage of development, territory and estimated launch date?
Key Players
- REVA Medical Inc
- Rontis AG
- S3V Vascular Technologies
- Sahajanand Medical Technologies Pvt Ltd
- Shanghai Bio-heart Biological Technology Co Ltd
- Stentys SA
- Svelte Medical Systems Inc
- Tepha Inc
- Terumo Corp
- TissueGen Inc
- TrendyMED Inc.
- VasoTech Inc.
- Viller Scientific LLC
- Vornia Biomaterials Ltd
- Xenogenics Corporation
- Biotronik AG
- Cardionovum GmbH
- Concept Medical Inc
- Contego Medical LLC
- Cordis Corp
- DISA Vascular (Pty) Ltd
- Elixir Medical Corp
- Envision Scientific Pvt Ltd
- Aachen Resonance GmbH
- Abbott Vascular Inc
- Adcomp Technologies Inc.
- Aeon Bioscience
- AlviMedica Medical Technologies Inc
- Amaranth Medical Inc
- Arterius Ltd
- Atrium Medical Corp
- Bactiguard Holding AB
- Bionext Biotech Products Ltd.
- Biosten, LLC
- Systems, Inc.
- ID Nest Medical SAS
- InspireMD Inc
- Japan Stent Technology Co., Ltd.
- JW Medical Systems Ltd
- Kaneka Corp
- Kyoto Medical Planning Co Ltd
- Liaoning Biomedical Materials R&D Center Co Ltd
- Lifetech Scientific (Shenzhen) Co Ltd
- MangoGen Pharma Inc
- Manli Cardiology Ltd
- Medinol Ltd
- Medtronic plc
- Miami Cardiovascular Innovations
- Micell Technologies Inc
- MicroPort Scientific Corp
- Minvasys SAS
- MIV Therapeutics Inc
- NanoCoeur, Inc.
- Nanova, Inc
- Nesstent Ltd.
- Nexeon MedSystems Inc
- NuVascular Technologies Inc
- OrbusNeich
- Pediastent LLC
- QualiMed Innovative Medizinprodukte GmbH
- Qvanteq AG
- Relisys Medical Devices Ltd
For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/1aoejj
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900